Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DEC NYSE:SQZ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDECDiversified Energy$15.96+2.0%$15.69$12.33▼$18.90$1.16B-0.34925,620 shs139,811 shsSQZSQZ Biotechnologies$0.02$0.02$0.25▼$3.56$708K2.34455,220 shs400 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDECDiversified Energy0.00%-4.97%-6.49%+16.33%+19.25%SQZSQZ Biotechnologies0.00%0.00%0.00%0.00%-14.29%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDECDiversified Energy$15.96+2.0%$15.69$12.33▼$18.90$1.16B-0.34925,620 shs139,811 shsSQZSQZ Biotechnologies$0.02$0.02$0.25▼$3.56$708K2.34455,220 shs400 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDECDiversified Energy0.00%-4.97%-6.49%+16.33%+19.25%SQZSQZ Biotechnologies0.00%0.00%0.00%0.00%-14.29%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDECDiversified Energy 2.78Moderate Buy$21.8336.81% UpsideSQZSQZ Biotechnologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PTAL, SQZ, DEC, and RKH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/7/2026DECDiversified Energy Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)4/15/2026DECDiversified Energy StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$24.004/15/2026DECDiversified Energy StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$24.004/9/2026DECDiversified Energy Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$22.00 ➝ $20.004/2/2026DECDiversified Energy KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$18.00 ➝ $20.003/25/2026DECDiversified Energy Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold3/24/2026DECDiversified Energy Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$22.003/23/2026DECDiversified Energy Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy3/17/2026DECDiversified Energy CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$15.00 ➝ $17.003/2/2026DECDiversified Energy Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D+) ➝ Hold (C-)(Data available from 5/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDECDiversified Energy$1.83B0.63$8.14 per share1.96$8.54 per share1.87SQZSQZ Biotechnologies$18.16M0.04N/AN/A$1.94 per share0.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDECDiversified Energy$341.11M$1.4710.876.33N/AN/AN/AN/A7/29/2026 (Estimated)SQZSQZ Biotechnologies-$79.46M-$2.61N/AN/AN/A-369.96%-119.83%-59.90%N/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDECDiversified Energy$1.167.27%N/A78.91%N/ASQZSQZ BiotechnologiesN/AN/AN/AN/AN/ALatest PTAL, SQZ, DEC, and RKH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2026DECDiversified Energyquarterly$0.297.56%8/28/20268/28/20269/30/20262/26/2026DECDiversified Energyquarterly$0.298.79%5/29/20265/29/20266/30/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDECDiversified Energy3.570.470.47SQZSQZ BiotechnologiesN/A3.503.50Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDECDiversified Energy26.51%SQZSQZ Biotechnologies38.51%Insider OwnershipCompanyInsider OwnershipDECDiversified Energy2.90%SQZSQZ Biotechnologies16.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDECDiversified Energy1,98772.32 million70.23 millionN/ASQZSQZ Biotechnologies1,62029.49 million24.77 millionNot OptionablePTAL, SQZ, DEC, and RKH HeadlinesRecent News About These CompaniesArsenal Yards attracts another life sciences tenantApril 23, 2026 | bizjournals.comFinancial Comparison: SQZ Biotechnologies (NYSE:SQZ) vs. Cortexyme (NASDAQ:CRTX)March 22, 2026 | defenseworld.netDSerica Energy reveals impact of Triton downtime, eyes volume recovery “soonâ€August 5, 2025 | proactiveinvestors.co.ukSQZB SQZ Biotechnologies Company - Seeking AlphaJuly 9, 2025 | seekingalpha.comSerica Energy shares drop as Triton suspended until mid-MarchFebruary 18, 2025 | proactiveinvestors.co.ukSerica Energy says 2025 outlook is ‘promising'January 21, 2025 | proactiveinvestors.co.ukSerica Energy expects to remedy “clearly disappointing†recent production performanceJanuary 7, 2025 | proactiveinvestors.co.ukSQZ Biotechnologies Co Ordinary SharesDecember 23, 2024 | morningstar.comMPortal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA VenturesDecember 19, 2024 | finance.yahoo.comGlobal Short-Acting Insulin Market is Expected to Cross ~USD 9 Billion by 2030 | DelveInsightSeptember 5, 2024 | prnewswire.co.ukPSTEMCELL Launches Novel Cell-Engineering CellPore™ Transfection SystemAugust 1, 2024 | valdostadailytimes.comVWhat is the price tag to keep the biotech engine humming in Massachusetts?July 23, 2024 | msn.comSQZ Biotechnologies Company (SQZB)May 22, 2024 | finance.yahoo.comSqz Bio (SQZB) Earnings Dates & ReportsMay 8, 2024 | investing.comVC funding update: who raised money in March?April 1, 2024 | bizjournals.comSQZ, Portal founder Armon Sharei on starting over in biotechMarch 26, 2024 | biopharmadive.comBPortal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VCMarch 19, 2024 | finance.yahoo.comSQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to StemcellMarch 1, 2024 | fiercebiotech.comFRx Rundown: Gilead Sciences, Latigo Biotherapeutics, Exscientia and moreFebruary 16, 2024 | mmm-online.comMSQZB SQZ Biotechnologies CompanyDecember 28, 2023 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThese are the 3 Biggest AI Winners and Losers of 2026By Leo Miller | April 13, 20263 Retail Stocks to Watch for a Post-Tax-Day BumpBy Nathan Reiff | April 13, 2026Tractor Supply’s 10% Culling: A Bruise, Not a BreakBy Jeffrey Neal Johnson | April 22, 2026What's Behind D-Wave's Spring Rally, and Will It Continue?By Nathan Reiff | April 20, 2026Homebuilder Earnings: D.R. Horton Sticks Out as Pulte & NVR Sales TankBy Leo Miller | April 27, 2026PTAL, SQZ, DEC, and RKH Company DescriptionsDiversified Energy NYSE:DEC$15.96 +0.31 (+1.97%) As of 10:45 AM Eastern This is a fair market value price provided by Massive. Learn more.Diversified Energy Company PLC operates as an independent owner and operator of producing natural gas and oil wells primarily in the Appalachian Basin of the United States. The company is involved in the production, marketing, and transportation of natural gas, natural gas liquids, crude oil, and condensates. Its assets consist of natural gas wells and gathering systems located in the states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company was formerly known as Diversified Gas & Oil PLC and changed its name to Diversified Energy Company PLC in May 2021. Diversified Energy Company PLC was founded in 2001 and is headquartered in Birmingham, Alabama.SQZ Biotechnologies NYSE:SQZ$0.02 0.00 (0.00%) As of 05/8/2026SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tapestry Stock Drops After Strong Quarter and Raised Outlook MarketBeat Week in Review – 05/04 - 05/08 Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance The Stars Are Aligning For Apple: Get Ready for $300 3 Under-The-Radar Small Caps Making New All-Time Highs Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
